HealthDay - SUNDAY, April 19 (HealthDay News) -- Patients with a variety of advanced cancers who had been faring poorly on less finely tuned therapies did better when they received treatments that were targeted to their tumors' specific characteristics.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.